57
In band
Moving averages
SMA 200$14.73+28.72%
Company profile
MorphoSys AG, discovers, develops and markets therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. The company is headquartered in Planegg, Germany.
SectorHealthcare
IndustryBiotechnology
Market cap$2.86B
P/E ratioNone
EPS$-1.50
Beta0.662
Dividend yield0.00%
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 48
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 59
IOVA
Iovance Biotherapeutics Inc
RSI 74
MRNA
Moderna Inc
RSI 70
VKTX
Viking Therapeutics Inc
RSI 39
SRPT
Sarepta Therapeutics Inc
RSI 50
EDIT
Editas Medicine Inc
RSI 48
NVAX
Novavax Inc
RSI 65
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 61
RSI alerts for MOR
Get an email the moment MorphoSys AG ADR crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 15 September 2026 at 4:56 AM EDT